The Current Ratio as of December 2025 (TTM) for Magle Chemoswed Holding AB (publ) (MAGLE.ST) is 1.96

According to Magle Chemoswed Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 1.96. This represents a change of 106.45% compared to the average of 0.95 of the last 4 quarters.

Magle Chemoswed Holding AB (publ) (MAGLE.ST) Historical Current Ratio (quarterly & annually)

How has MAGLE.ST Current Ratio performed in the past?

The mean historical Current Ratio of Magle Chemoswed Holding AB (publ) over the last ten years is 1.03. The current 1.96 Current Ratio has changed 19.01% with respect to the historical average. Over the past ten years (40 quarters), MAGLE.ST's Current Ratio was at its highest in in the September 2025 quarter at 1.96. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Magle Chemoswed Holding AB (publ) (MAGLE.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Magle Chemoswed Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Magle Chemoswed Holding AB (publ) (MAGLE.ST) Average Current Ratio

How has MAGLE.ST Current Ratio performed in the past?

The current Current Ratio of Magle Chemoswed Holding AB (publ) (MAGLE.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Magle Chemoswed Holding AB (publ) (MAGLE.ST) Current Ratio vs. Peers

How is MAGLE.ST’s Current Ratio compared to its peers?

Magle Chemoswed Holding AB (publ)’s Current Ratio is less than Mendus AB (publ) (2.47), less than Ascelia Pharma AB (publ) (3.60), greater than Corline Biomedical AB (1.52), less than Elicera Therapeutics AB (publ) (5.35), less than Intervacc AB (publ) (11.00), greater than Xintela AB (publ) (0.23), less than Moberg Pharma AB (publ) (16.14), less than Karolinska Development AB (publ) (7.99), less than Bio-Works Technologies AB (publ) (2.26), greater than IRLAB Therapeutics AB (publ) (1.30),

Build a custom stock screener for Magle Chemoswed Holding AB (publ) (MAGLE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Magle Chemoswed Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Magle Chemoswed Holding AB (publ) (MAGLE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Magle Chemoswed Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.